AI to help interpret cardiac CT was shown to reduce exam read times to improve workflow efficiency, and improve patient diagnostics with additional information on soft plaques. Data was presented in three HeartFlow AI technology studies at SCCT 2023.

The FDA sent notice today that Abbott is pulling the Trifecta aortic surgical heart valve off the U.S. market due to the risk of early structural valve deterioration in less than 5 years. 

The FDA approved UltraSight's AI to show ultrasound users how to perform a diagnostic quality cardiac ultrasound exam at the point of care in multiple settings.

There is a risk of the devices sending a reduced amount of energy to the heart during defibrillation. More than 7,000 devices are being recalled due to this issue.

Creating these complex structures with 3D printing alone has never been possible—until now. 

There have been 30 complaints so far about this issue, including 26 injuries and four deaths.

The FDA has categorized this as a Class I recall, which means using the devices “may cause serious injuries or death.”

The college issued a detailed breakdown of the 2024 MPFS, offering insight into the “complex” formula for how much the specialty stands to lose. 

The world’s most popular supplier of cloud services has become a dedicated radiology vendor.